You have 9 free searches left this month | for more free features.

Condition

Alzheimer's Disease (1)

Alzheimers Disease (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Amgen (1)

Banner Alzheimer's Institute (1)

National Institute on Aging (NIA) (1)

Intervention

cnp520 (2)

alum (1)

cad106 immunotherapy (1)

placebo (1)

placebo to cad106 (1)

placebo to cnp520 (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

cnp520

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Alzheimers Disease Trial in Worldwide (biological, other, drug)

Terminated

Alzheimers Disease

CAD106 Immunotherapy
+4 more

Phoenix, Arizona
+128 more

Jul 7, 2021

Alzheimer's Disease Trial in Worldwide (CNP520, Placebo)

Completed

Alzheimer's Disease

CNP520
Placebo

Glendale, California
+10 more

Aug 7, 2017